• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOA:LN

124.20 GBp 0.60 0.49%

As of 00:59:30 ET on 09/01/2014.

Snapshot for AXA Framlington Biotech Fund (FRABIOA)

Year To Date: +21.03% 3-Month: +16.64% 3-Year: +41.08% 52-Week Range: 90.09 - 124.50
1-Month: +8.86% 1-Year: +30.25% 5-Year: +23.83% Beta vs NBI: 0.96

Mutual Fund Chart for FRABIOA

No chart data available.
  • FRABIOA:LN 124.20
  • 1M
  • 1Y
Interactive FRABIOA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOA

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 11-26-2001 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOA

NAV (on 2014-09-01) 124.20
Assets (M) (on 2014-06-30) 326.10
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for FRABIOA

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOA

Front Load 5.50
Back Load 0.00
Current Mgmt Fee 1.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.95

Top Fund Holdings for FRABIOA

Filing Date: 02/28/2014
Name Position Value % of Total
Gilead Sciences Inc 619,422 30,656,400 8.660%
Celgene Corp 284,757 27,364,200 7.730%
Amgen Inc 354,795 26,160,599 7.390%
Biogen Idec Inc 116,285 23,682,600 6.690%
Illumina Inc 199,588 20,461,200 5.780%
Regeneron Pharmaceuticals Inc 75,691 15,045,000 4.250%
BioMarin Pharmaceutical Inc 258,069 12,496,200 3.530%
Vertex Pharmaceuticals Inc 249,728 12,071,400 3.410%
Alexion Pharmaceuticals Inc 110,529 11,682,000 3.300%
Incyte Corp 281,064 10,797,000 3.050%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil